meperidine and n,n-dimethyl-3,3-diphenyl-1-methylallylamine

meperidine has been researched along with n,n-dimethyl-3,3-diphenyl-1-methylallylamine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kjaer, M; Nielsen, H1
Breivik, H; Raeder, JC; van der Linden, J1
Grosman, N1
Anderson, P; Arnér, S; Bondesson, U; Boréus, LO; Hartvig, P1
Christensen, CB; Christrup, LL; Kristensen, K; Nielsen, LC1
Andersen, S; Ebert, B; Thorkildsen, C1

Trials

1 trial(s) available for meperidine and n,n-dimethyl-3,3-diphenyl-1-methylallylamine

ArticleYear
Premedication for day-case surgery: double-blind comparison of ketobemidone + dimethylaminodiphenylbuten (A-29) and morphine + scopolamine.
    Acta anaesthesiologica Scandinavica, 1986, Volume: 30, Issue:7

    Topics: Abortion, Legal; Adolescent; Adult; Allylamine; Ambulatory Surgical Procedures; Amines; Anesthesia, General; Dilatation and Curettage; Drug Therapy, Combination; Female; Humans; Meperidine; Middle Aged; Morphine; Nitrous Oxide; Preanesthetic Medication; Pregnancy; Scopolamine; Thiopental

1986

Other Studies

5 other study(ies) available for meperidine and n,n-dimethyl-3,3-diphenyl-1-methylallylamine

ArticleYear
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
    Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:5

    Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets

1988
Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29.
    Acta pharmacologica et toxicologica, 1982, Volume: 50, Issue:1

    Topics: Allylamine; Analgesics, Opioid; Animals; Basophils; Butylamines; Histamine Release; Humans; In Vitro Techniques; Mast Cells; Meperidine; Morphine; Parasympatholytics; Rats; Rats, Inbred Strains

1982
Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.
    European journal of clinical pharmacology, 1981, Volume: 19, Issue:3

    Topics: Adult; Allylamine; Biological Availability; Humans; Injections, Intravenous; Kinetics; Male; Meperidine; Parasympatholytics; Rectum; Suppositories

1981
The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene.
    Pharmacology & toxicology, 1996, Volume: 79, Issue:2

    Topics: Allylamine; Analgesics, Opioid; Animals; Binding, Competitive; Cattle; Caudate Nucleus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Humans; Isonipecotic Acids; Meperidine; Parasympatholytics; Phenols; Receptors, Opioid, delta; Receptors, Opioid, mu

1996
Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist.
    Pharmacology & toxicology, 1998, Volume: 82, Issue:3

    Topics: Allylamine; Analgesics, Opioid; Animals; Cerebral Cortex; Excitatory Amino Acid Antagonists; Membrane Potentials; Meperidine; Rats; Receptors, N-Methyl-D-Aspartate

1998